Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Oxytrol submission accepted for review in Canada

May 28, 2003

Solifenacin succinate safe and effective in patients with overactive bladder

May 26, 2003

Favorable effects on bone disease reported for lanthanum carbonate in hemodialysis

May 23, 2003

New data on vardenafil reported at the American Geriatrics Society meeting

May 20, 2003

17Beta-HSD-3 inhibitors in early development at Schering-Plough

May 19, 2003

Phase IIa trial evaluates VR-004 delivered via lungs for ED

May 15, 2003

At-home phase IIb study begins for ED treatment PT-141

May 15, 2003

Novartis acquires Enablex

May 13, 2003

5-HT1A antagonists with utility in urinary tract disorders under study at Recordati

May 13, 2003

Licensing opportunity from Milkhaus: ML-04 for BPH and prostatitis

May 12, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...